IL-23 and autoimmunity: New insights into the pathogenesis of inflammatory bowel disease

Annual Review of Medicine

Volumn 60, Issue , 2009, Pages 97-110

  Abraham, Clara ^a   Cho, Judy H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crohn's disease; Genome wide association studies; Intestine; Th17 cells; Ulcerative colitis

Indexed keywords

INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AIN 457; SIMVASTATIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL FEATURE; CROHN DISEASE; DISEASE ACTIVITY; EFFECTOR CELL; ENTERITIS; GENETIC DISORDER; HEREDITY; HUMAN; INTESTINE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TH17 CELL; ULCERATIVE COLITIS;

ARRHYTHMIAS, CARDIAC; AUTOIMMUNITY; HOMEOSTASIS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-23;

EID: 60849138547     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.60.051407.123757     Document Type: Review

References (99)

1. Elson CO, Cong Y,Weaver CT, et al. 2007. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132:2359-70
2. Kullberg MC, Jankovic D, Feng CG, et al. 2006. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203:2485-94
3. Yen D, Cheung J, Scheerens H, et al. 2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116:1310-16
4. Fujino S, Andoh A, Bamba S, et al. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65-70
5. Schmidt C, Giese T, Ludwig B, et al. 2005. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm. Bowel Dis. 11:16-23
6. Annunziato F, Cosmi L, Santarlasci V, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204:1849-61
7. Holtta V, Klemetti P, Sipponen T, et al. 2008. IL-23/IL-17 immunity as a hallmark of Crohn's disease. Inflamm. Bowel Dis. 14:1175-84
8. + regulatory T cells in Crohn's disease. Clin. Immunol. 125:281-90
9. Fina D, Sarra M, Fantini MC, et al. 2008. Regulation of gut inflammation and Th17 cell response by interleukin-21. Gastroenterology 134:1038-48
10. Duerr RH, Taylor KD, Brant SR, et al. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461-63
11. Cargill M, Schrodi SJ, Chang M, et al. 2007. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80:273-90
12. Burton PR, Clayton DG, Cardon LR, et al. 2007. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39:1329-37
13. Loftus EV Jr, Sandborn WJ. 2002. Epidemiology of inflammatory bowel disease. Gastroenterol. Clin. North Am. 31:1-20
14. Urlep D, Mamula P, Baldassano R. 2005. Extraintestinal manifestations of inflammatory bowel disease. Minerva Gastroenterol. Dietol. 51:147-63
15. Podolsky DK. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347:417-29
16. Loftus EV Jr, Schoenfeld P, Sandborn WJ. 2002. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment. Pharmacol. Ther. 16:51-60
17. Satsangi J, Jewell DP, Bell JI. 1997. The genetics of inflammatory bowel disease. Gut 40:572-74
18. Halfvarson J, Bodin L, Tysk C, et al. 2003. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 124:1767-73
19. Orholm M, Binder V, Sorensen TI, et al. 2000. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand. J. Gastroenterol. 35:1075-81
20. Thompson NP, Driscoll R, Pounder RE, et al. 1996. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 312:95-96
21. Tysk C, Lindberg E, Jarnerot G, et al. 1988. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29:990-96
22. Barrett JC, Hansoul S, Nicolae DL, et al. 2008. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40:955-62
23. Hampe J, Franke A, Rosenstiel P, et al. 2007. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39:207-11
24. Rioux JD, Xavier RJ, Taylor KD, et al. 2007. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39:596-604
25. Parkes M, Barrett JC, Prescott NJ, et al. 2007. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 39:830-32
26. WellcomeTrust Case Control Consortium. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661-78
27. Xavier RJ, Podolsky DK. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427-34
28. Mosmann TR, Cherwinski H, BondMW,et al. 1986.Two types of murine helperTcell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-57
29. Bettelli E, Korn T, Oukka M, et al. 2008. Induction and effector functions ofTH17 cells. Nature 453:1051-57
30. Happel KI, Zheng M, Young E, et al. 2003. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170:4432-36
31. H17 lineage. Nature 441:231-34
32. Izcue A, Powrie F. 2008. Special regulatory T-cell review: regulatory T cells and the intestinal tract - patrolling the frontier. Immunology 123:6-10
33. H-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγτ Nat. Immunol. 9:641-49
34. Wilson NJ, Boniface K, Chan JR, et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8:950-57
35. H17 cells. Nature 454:350-52
36. H-17 responses. Nat. Immunol. 9:650-57
37. Bettelli E, Carrier Y, Gao W, et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-38
38. Veldhoen M, Hocking RJ, Atkins CJ, et al. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-89
39. Langrish CL, Chen Y, Blumenschein WM, et al. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-40
40. Cua DJ, Sherlock J, Chen Y, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744-48
41. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-32
42. McGeachy MJ, Bak-Jensen KS, Chen Y, et al. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat. Immunol. 8:1390-97
43. Stark MA, Huo Y, Burcin TL, et al. 2005. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22:285-94
44. Lovato P, Brender C, Agnholt J, et al. 2003. Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease. J. Biol. Chem. 278:16777-81
45. Caprioli F, Sarra M, Caruso R, et al. 2008. Autocrine regulation of IL-21 production in human T lymphocytes. J. Immunol. 180:1800-7
46. Mudter J, Weigmann B, Bartsch B, et al. 2005. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am. J. Gastroenterol. 100:64-72
47. Pe'er I, de Bakker PI, Maller J, et al. 2006. Evaluating and improving power in whole-genome association studies using fixed marker sets. Nat. Genet. 38:663-67
48. Parham C, Chirica M, Timans J, et al. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168:5699-708
49. Oppmann B, Lesley R, Blom B, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-25
50. Musso A, Dentelli P, Carlino A, et al. 2005. Signal transducers and activators of transcription 3 signaling pathway: an essential mediator of inflammatory bowel disease and other forms of intestinal inflammation. Inflamm. Bowel Dis. 11:91-98
51. Rosenstiel P, Agnholt J, Kelsen J, et al. 2005. Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease. Gut 54:314-15
52. Suzuki A, Hanada T, Mitsuyama K, et al. 2001. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J. Exp. Med. 193:471-81
53. Wu F, Dassopoulos T, Cope L, et al. 2007. Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm. Bowel Dis. 13:807-21
54. Staples KJ, Smallie T,Williams LM, et al. 2007. IL-10 induces IL-10 in primary human monocyte-derived macrophages via the transcription factor Stat3. J. Immunol. 178:4779-85
55. Williams L, Bradley L, Smith A, et al. 2004. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 172:567-76
56. Chen Z, O'Shea JJ. 2008. Th17 cells: a new fate for differentiating helper T cells. Immunol. Res. 41:87-102
57. Kobayashi M, Kweon MN, Kuwata H, et al. 2003. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J. Clin. Invest. 111:1297-308
58. Welte T, Zhang SS,Wang T, et al. 2003. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc. Natl. Acad. Sci. USA 100:1879-84
59. Salazar-Gonzalez RM, Niess JH, Zammit DJ, et al. 2006. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches. Immunity 24:623-32
60. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, et al. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942-49
61. + effector memory T cells. J. Immunol. 180:7948-57
62. Singh SP, Zhang HH, Foley JF, et al. 2008. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J. Immunol. 180:214-21
63. Yamazaki K, McGovern D, Ragoussis J, et al. 2005. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum. Mol. Genet. 14:3499-506
64. Picornell Y, Mei L, Taylor K, et al. 2007. TNFSF15 is an ethnic-specific IBD gene. Inflamm. Bowel Dis. 13:1333-38
65. Tremelling M, Berzuini C, Massey D, et al. 2008. Contribution of TNFSF15 gene variants to Crohn's disease susceptibility confirmed in UK population. Inflamm. Bowel Dis. 14:733-37
66. Pappu BP, Borodovsky A, Zheng TS, et al. 2008. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp. Med. 205:1049-62
67. Bamias G, Martin C 3rd, Marini M, et al. 2003. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 171:4868-74
68. + T lymphocytes. J. Immunol. 174:4985-90
69. Fang L, Adkins B, Deyev V, et al. 2008. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J. Exp. Med. 205:1037-48
70. Fisher SA, Tremelling M, Anderson CA, et al. 2008. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat. Genet. 40:710-12
71. Franke A, Balschun T, Karlsen TH, et al. 2008. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat. Genet. 40:713-15
72. Becker C, Wirtz S, Blessing M, et al. 2003. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J. Clin. Invest. 112:693-706
73. + T helper cells. Cell 126:1121-33
74. Kryczek I,Wei S, Zou L, et al. 2007. Cutting edge: Th17 and regulatoryTcell dynamics and the regulation by IL-2 in the tumor microenvironment. J. Immunol. 178:6730-33
75. Izcue A, Hue S, Buonocore S, et al. 2008. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 28:559-70
76. Sun CM, Hall JA, Blank RB, et al. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204:1775-85
77. Mucida D, Park Y, Kim G, et al. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256-60
78. Elias KM, Laurence A, Davidson TS, et al. 2008. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111:1013-20
79. + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204:1757-64
80. van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, et al. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27:660-69
81. LeibundGut-Landmann S, Gross O, Robinson MJ, et al. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8:630-38
82. Gerosa F, Baldani-Guerra B, Lyakh LA, et al. 2008. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 205:1447-61
83. Cheung PF,Wong CK, Lam CW. 2008. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J. Immunol. 180:5625-35
84. Kanda N, Watanabe S. 2008. IL-12, IL-23, and IL-27 enhance human beta-defensin-2 production in human keratinocytes. Eur. J. Immunol. 38:1287-96
85. Hue S, Ahern P, Buonocore S, et al. 2006. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203:2473-83
86. Uhlig HH, McKenzie BS, Hue S, et al. 2006. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25:309-18
87. Kamada N, Hisamatsu T, Okamoto S, et al. 2005. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J. Immunol. 175:6900-8
88. + T cell-induced colitis. Eur. J. Immunol. 33:1073-83
89. Wiekowski MT, Leach MW, Evans EW, et al. 2001. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J. Immunol. 166:7563-70
90. Sugimoto K, Ogawa A, Mizoguchi E, et al. 2008. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118:534-44
91. Zenewicz LA, Yancopoulos GD, Valenzuela DM, et al. 2007. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27:647-59
92. Solem CA, Loftus EV Jr, Tremaine WJ, et al. 2005. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm. Bowel Dis. 11:707-12
93. Kader HA,Tchernev VT, Satyaraj E, et al. 2005. Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease. Am. J. Gastroenterol. 100:414-23
94. Holscher C. 2004. The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med. Microbiol. Immunol. 193:1-17
95. Kamada N, Hisamatsu T, Okamoto S, et al. 2008. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J. Clin. Invest. 118:2269-80
96. Fuss IJ, Becker C, Yang Z, et al. 2006. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm. Bowel Dis. 12:9-15
97. Mannon PJ, Fuss IJ, Mayer L, et al. 2004. Anti-interleukin-12 antibody for active Crohn's disease. N. Engl. J. Med. 351:2069-79
98. Ouyang W, Kolls JK, Zheng Y. 2008. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28:454-67
99. + lymphocytes. J. Immunol. 180:6988-96